<DOC>
	<DOCNO>NCT00047320</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy work different way stop tumor cell divide stop grow die . Giving chemotherapy drug surgery may shrink tumor longer present conventional image tumor marker serum cerebrospinal fluid . Radiation therapy use high-energy x-rays damage tumor cell . Peripheral stem cell transplantation may allow doctor give high dos chemotherapy drug kill tumor cell . Combining different type therapy may kill tumor cell . PURPOSE : This Phase II trial study well neoadjuvant chemotherapy without surgery without high dose chemotherapy peripheral stem cell transplantation , increase response rate prior radiation therapy increase progression free overall surviving patient newly diagnose intracranial germ cell tumor .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy With Without Second-Look Surgery Followed Radiation Therapy With Without Peripheral Stem Cell Transplantation Treating Patients With Intracranial Germ Cell Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate patient non-germinomatous germ cell tumor treat neoadjuvant chemotherapy . - Determine progression-free survival overall survival patient treat neoadjuvant chemotherapy without second-look surgery follow radiotherapy without autologous peripheral blood stem cell transplantation ( PBSCT ) . - Determine whether additional complete response achieve high-dose thiotepa etoposide PBSCT patient persistently positive marker , histological evidence residual malignant element , unresectable residual tumor initial neoadjuvant chemotherapy . - Determine pattern recurrence patient treat regimen . - Correlate tumor marker response radiographic clinical measure response , well find second-look surgery patient radiological evidence residual disease . OUTLINE : - Induction chemotherapy : - Courses 1 , 3 , 5 : Patients receive carboplatin IV 1 hour day 1 etoposide IV 1 hour day 1-3 . Beginning day 4 , patient receive filgrastim ( G-CSF ) IV subcutaneously ( SC ) 10 day blood count recover . Courses 3 week duration . - Courses 2 , 4 , 6 : Patients receive etoposide IV 1 hour follow ifosfamide IV 1 hour day 1-5 . Beginning day 6 , patient receive G-CSF IV SC 10 day blood count recover . Courses 3 week duration . Patients undergo re-evaluation . Patients complete response ( CR ) go directly radiotherapy . Approximately 3 week completion induction chemotherapy , patient less CR encourage undergo second-look surgery . After second-look surgery , patient CR partial response ( PR ) go directly radiotherapy . Patients less PR undergo consolidation chemotherapy peripheral blood stem cell rescue ( PBSC ) follow radiotherapy . - Consolidation chemotherapy : Patients undergo PBSC collection . Patients receive G-CSF SC PBSC collection complete . Patients receive thiotepa IV 3 hour follow etoposide IV 3 hour day -5 -3 . PBSCs reinfused day 0 . Beginning day 1 continue blood count recover , patient receive G-CSF SC daily . - Radiotherapy : All patient receive radiotherapy daily 5 day week 5-6 week begin recovery induction chemotherapy second-look surgery within 9 week PBSC reinfusion . Patients follow every 3 month 1 year , every 4 month 1 year , every 6 month 1 year , annually thereafter . PROJECTED ACCRUAL : A total 80-100 patient accrue study within 36-42 month .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One follow diagnosis : Histologically confirm intracranial nongerminomatous germ cell tumor ( NGGCT ) 1 follow type : Endodermal sinus tumor ( yolk sac tumor ) Embryonal carcinoma Choriocarcinoma Immature teratoma teratoma malignant transformation Mixed germ cell tumor Histologically confirm germinoma elevation serum/CSF beta human chorionic gonadotropin ( HCG ) level great 50 mIU/mL serum/CSF alphafetoprotein ( AFP ) level great 10 ng/ml institutional norm Histologically unconfirmed pineal and/or suprasellar tumor serum/CSF beta HCG level great 50 mIU/mL AFP level great 10 ng/ml institutional norm Patients normal AFP beta HCG &lt; 50 mIU/mL without histologic diagnosis NGGCT patient pure germinoma without elevation tumor marker ineligible Initial diagnosis within past 31 day PATIENT CHARACTERISTICS : Age 3 24 diagnosis Performance status No minimum performance level Life expectancy At least 8 week Hematopoietic Absolute neutrophil count least 1,000/mm^3 Platelet count least 100,000/mm^3 ( transfusion independent ) Hemoglobin least 10.0 g/dL ( transfusion allow ) Hepatic Bilirubin great 1.5 time upper limit normal ( ULN ) ALT great 2.5 time ULN Renal Creatinine great 1.5 time ULN OR Creatinine clearance radioisotope glomerular filtration rate least 70 mL/min Pulmonary No assist ventilation Other Seizure disorder allow No patient status coma Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Prior corticosteroid allow Concurrent corticosteroid allow Concurrent endocrine replacement therapy allow ( e.g. , Lthyroxine , testosterone , estrogen , desmopressin acetate ) No concurrent growth hormone therapy Radiotherapy Not specify Surgery More 1 prior surgery allow Other No prior therapy malignancy</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
	<keyword>childhood central nervous system choriocarcinoma</keyword>
	<keyword>childhood central nervous system embryonal tumor</keyword>
	<keyword>childhood central nervous system germinoma</keyword>
	<keyword>childhood central nervous system mixed germ cell tumor</keyword>
	<keyword>childhood central nervous system teratoma</keyword>
	<keyword>childhood central nervous system yolk sac tumor</keyword>
	<keyword>recurrent childhood central nervous system embryonal tumor</keyword>
</DOC>